Septic acute renal failure

Contributions to Nephrology

Volumn 166, Issue , 2010, Pages 40-46

  Mori, Tsuyoshi ^a   Shimizu, Tomoharu ^a   Tani, Tohru ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; HUMAN; METHODOLOGY; MORTALITY; RENAL REPLACEMENT THERAPY; REVIEW; SEPSIS;

HUMANS; KIDNEY FAILURE, ACUTE; RENAL REPLACEMENT THERAPY; SEPSIS;

EID: 84925941371     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000314849     Document Type: Article

References (26)

1. Bagga A, Bakkaloglu A, Devarajan P, Mehta RL, Kellum JA, Shah S V, Molitoris BA, Ronco C, Warnock DG, Joannidis M, Levin A: Improving outcomes from acute kidney injury: report of an initiative. Pediatr Nephrol 2007;22:1655-1658.
2. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP: The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 1995;273:117-123.
3. Uchino S, Kellum JA: Acute renal failure in critically ill patients. JAMA 2005;294:813-818.
4. Schrier RW, Wang W: Acute renal failure and sepsis. N Engl J Med 2004;351:159-169.
5. Bellomo R, Wan L, Langenberg C, May C: Septic acute kidney injury: new concepts. Nephron Exp Nephrol 2008;109: e95-e100.
6. Aoki H, Kodama M, Tani T, Hanasawa K: Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber. Am J Surg 1994;167:412-417.
7. Vincent JL, Laterre PF, Cohen J, Burchardi H, Bruining H, Lerma FA, Wittebole X, De Backer D, Brett S, Marzo D, Nakamura H, John S: A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 2005;23:400-405.
8. Nakamura T, Kawagoe Y, Matsuda T, Ueda Y, Koide H: Effects of polymyxin B immobilized fiber on urinary N-acetyl-betaglucosaminidase in patients with severe sepsis. ASAIO J 2004;50:563-567.
9. Cantaluppi V, Assenzio B, Pasero D, Romanazzi GM, Pacitti A, Lanfranco G, Puntorieri V, Martin EL, Mascia L, Monti G, Casella G, Segoloni G P, Camussi G, Ranieri VM: Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors. Intensive Care Med 2008;34:1638-1645.
10. Matsuda K, Moriguchi T, Harii N: Comparison of efficacy between continuous hemodiafiltration with a PMMA membrane hemofilter and a PAN membrane hemofilter in the treatment of a patient with septic acute renal failure. Transfus Apher Sci 2009;40:49-53.
11. Taniguchi T, Hirai F, Takemoto Y, Tsuda K, Yamamoto K, Inaba H, Sakurai H, Furuyoshi S, Tani N: A novel adsorbent of circulating bacterial toxins and cytokines: the effect of direct hemoperfusion with CTR column for the treatment of experimental endotoxemia. Crit Care Med 2006;34:800-806.
12. Taniguchi T, Kurita A, Yamamoto K, Inaba H: Comparison of a cytokine adsorbing column and an endotoxin absorbing column for the treatment of experimental endotoxemia. Transfus Apher Sci 2009;40:55-59.
13. Liu KD, Himmelfarb J, Paganini E, Ikizler TA, Soroko SH, Mehta RL, Chertow GM: Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol 2006;1:915-919.
14. Palevsky PM: Timing and dose of continuous renal replacement therapy in acute kidney injury. Crit Care 2007;11:232.
15. Abichandani R, Pereira BJ: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial, by Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G. Lancet 355:26-30, 2000.
16. Semin Dial 2001;14:233-234.
17. Sugahara S, Suzuki H: Early start on continuous hemodialysis therapy improves survival rate in patients with acute renal failure following coronary bypass surgery. Hemodial Int 2004;8:320-325.
18. Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J: Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med 2002;30:2205-2211.
19. Rajapakse S, Rodrigo C, Rajapakse A, Kirthinanda D, Wijeratne S: Renal replacement therapy in sepsis-induced acute renal failure. Saudi J Kidney Dis Transpl 2009;20:553-559.
20. Bagshaw SM, Berthiaume LR, Delaney A, Bellomo R: Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: a metaanalysis. Crit Care Med 2008;36:610-617.
21. Pannu N, Klarenbach S, Wiebe N, Tonelli M, Alberta Kidney Disease Network: Renal replacement therapy in patients with acute renal failure: a systematic review. JAMA 2008;299:793-805.
22. Uchino S: Choice of therapy and renal recovery. Crit Care Med 2008;36: S238-S242.
23. Phu NH, Hien TT, Mai N, Chau TT, Chuong LV, Loc PP, Winearls C, Farrar J, White N, Day N: Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N Engl J Med 2002;347:895-902.
24. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G: Effects of different doses in continuous venovenous haemofiltration on outcomes of acute renal failure: a prospective randomized trial. Lancet 2000;356:26-30.
25. Tonelli M, Manns B, Feller-Kopman D: Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 2002;40:875-885.
26. Ronco C, Bonello M, Bordoni V, Ricci Z, D'Intini V, Bellomo R, Levin NW: Extracorporeal therapies in non-renal disease: treatment of sepsis and the peak concentration hypothesis. Blood Purif. 2004;22:164-174.